pristane has been researched along with Bright Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhamid, L; Cabana-Puig, X; Cecere, TE; Lee, J; LeRoith, T; Li, S; Li, Y; Luo, XM; Reilly, CM; Ross, AC; Sun, S; Swartwout, B; Wang, H; Werre, SR | 1 |
| Gilbert, L; Karvonen, K; Naides, SJ; Nykky, J; Pirttinen, H; Puttaraksa, K | 1 |
| Hodgin, JB; Kahlenberg, JM; Kaplan, MJ; Reed, TJ; Tsuji, NM; Yalavarthi, S; Zhao, W | 1 |
| Holdsworth, SR; Khouri, MB; Kitching, AR; Odobasic, D; Steinmetz, OM; Summers, SA; Yang, Y | 1 |
| Allaire, N; Bajko, J; Browning, JL; Chou, WC; Czerkowicz, JM; Dunstan, RW; Fu, K; Gardet, A; Kerns, HM; Lafyatis, R; Legault, HM; Lukashev, M; Rabah, D; Ranger, AM; Reynolds, TL; Ryan, S; Velez, DB; Viney, JL | 1 |
| Abliz, P; An, L; Guo, Q; Li, H; Lu, A; Meng, G; Niu, J; Wan, N; Wu, S; Xue, G; Yang, G; Yao, X | 1 |
| Kanwar, YS; Kumar, A; Reeves, WH; Satoh, M | 1 |
| Gudenkauf, L; McDonald, AH; Sanger, JR; Schneider, M; Weir, K | 1 |
| Jennette, JC; Kanwar, YS; Okano, T; Reeves, WH; Richards, HB; Satoh, M | 1 |
| Jennette, JC; Reeves, WH; Richards, HB; Satoh, M; Shaheen, VM; Shaw, M; Yoshida, H | 1 |
10 other study(ies) available for pristane and Bright Disease
| Article | Year |
|---|---|
Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus.
Topics: Animals; Bacterial Translocation; Contraindications, Drug; Dendritic Cells; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Drug Synergism; Dysbiosis; Female; Gastrointestinal Microbiome; Gene Expression Regulation; Glomerulonephritis; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Real-Time Polymerase Chain Reaction; RNA; RNA-Seq; Specific Pathogen-Free Organisms; Spleen; Terpenes; Tretinoin; Vitamin A | 2020 |
Parvovirus B19V Nonstructural Protein NS1 Induces Double-Stranded Deoxyribonucleic Acid Autoantibodies and End-Organ Damage in Nonautoimmune Mice.
Topics: Animals; Antibodies, Antinuclear; Apoptosis; Autoimmunity; Brain; DNA; Enzyme Inhibitors; Extracellular Vesicles; Female; Glomerulonephritis; Immunosuppressive Agents; Kidney Glomerulus; Liver; Mice; Myocardium; Parvovirus B19, Human; Staurosporine; Terpenes; Viral Nonstructural Proteins | 2019 |
An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.
Topics: Animals; Autoantibodies; Caspase 1; Cytokines; Disease Models, Animal; Endothelium, Vascular; Glomerulonephritis; Immune Complex Diseases; Immunosuppressive Agents; Inflammasomes; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Terpenes; Vascular Diseases; Vasodilation | 2014 |
Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Topics: Animals; Autoantibodies; Autoimmunity; Complement C3; Cytokines; Disease Models, Animal; Glomerulonephritis; Humans; Immunity, Humoral; Immunity, Innate; Immunoglobulin G; Interleukin-17; Kidney Glomerulus; Lupus Nephritis; Mice; Mice, Knockout; Spleen; Terpenes | 2014 |
Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis.
Topics: Animals; Autoantibodies; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Female; Fibrosis; Glomerulonephritis; Humans; Hypergammaglobulinemia; Inflammation; Kidney Tubules; Lupus Nephritis; Membrane Proteins; Mice; Terpenes; Transcription, Genetic; Up-Regulation | 2016 |
Hyperactivation of the NLRP3 Inflammasome in Myeloid Cells Leads to Severe Organ Damage in Experimental Lupus.
Topics: Animals; Antigen-Antibody Complex; Autoimmunity; Chemokines; Cytokines; Glomerulonephritis; Inflammation Mediators; Kidney; Lupus Erythematosus, Systemic; Mice; Myeloid Cells; Nephritis, Interstitial; NLR Family, Pyrin Domain-Containing 3 Protein; Terpenes | 2017 |
Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
Topics: Animals; Antibodies, Antinuclear; Autoantigens; Disease Models, Animal; DNA, Single-Stranded; Female; Glomerulonephritis; Histones; Immune Complex Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Proteins; Ribonucleoproteins, Small Nuclear; snRNP Core Proteins; Terpenes | 1995 |
Silicone gel enhances the development of autoimmune disease in New Zealand black mice but fails to induce it in BALB/cAnPt mice.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Disease Models, Animal; Female; Glomerulonephritis; Injections, Subcutaneous; Isotonic Solutions; Mice; Mice, Inbred BALB C; Mice, Inbred NZB; Proteinuria; Silicones; Species Specificity; Terpenes | 1998 |
Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Chromatin; DNA, Single-Stranded; Female; Glomerulonephritis; Immune Complex Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Nude; Proteins; Ribonucleoproteins; Ribonucleoproteins, Small Nuclear; snRNP Core Proteins; T-Lymphocytes; Terpenes | 1999 |
Immunopathogenesis of environmentally induced lupus in mice.
Topics: Animals; Antigen-Antibody Complex; Autoantibodies; Autoimmune Diseases; Disease Models, Animal; Environmental Exposure; Female; Glomerulonephritis; Granuloma; Humans; Lupus Erythematosus, Systemic; Mercuric Chloride; Mice; Mice, Inbred BALB C; Terpenes | 1999 |